The pill Qsymia from Mountain View-based Vivus Inc. was cleared for adults who are obese or overweight and have at least one weight-related condition such as high blood pressure, diabetes or high cholesterol.
Drugmaker Vivus Inc. said Monday that regulators will take another three months to make a decision on its closely-watched obesity drug Qnexa.
Obesity during pregnancy might increase chances for having a child with autism, according to new study out of University of California, Davis.
A 700-pound Livermore man’s plea for help to lose weight has become a viral sensation on YouTube in less than 24 hours.
The San Francisco Board of Supervisors is considering legislation relaxing restrictions on food trucks near city schools.
Santa Clara County’s Board of Supervisors voted Tuesday to approve the strictest nutrition standards in the country.
A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns.
A diet drug developed by a Bay Area company gets a second chance in front of the FDA.
A new study finds obese doctors were less likely to diagnose obesity in their patients.
Schools are in a constant battle to get more students to walk to school in an effort to improve their overall health.